Browse complete The Top 10 Eastern European Pharmaceutical Companies: Growth strategies, performance and SWOT analyses Report
Browse all Business Insights Market Research Reports
The Eastern European pharmaceutical companies comprise both Eastern Europe-based and MNCs. This chapter provides an insight into the current state of Eastern European pharmaceutical industry as well as the evolving trends. It also provides the competitive landscape of the industry based on financial and operational (revenue growth over the last five years, exposure to major markets and presence in major therapeutic areas) parameters in the Eastern European region.
The report also includes profiles of the top ten companies in the region and also gives a brief summary of top 11 to 20 players. The top 10 companies in the Eastern European pharmaceutical industry were assessed on following parameters:
- Each company’s market share in the Eastern European pharmaceutical market;
- Each company’s marketed products, geographic and therapeutic focus;
- Each company’s growth strategies and major acquisitions and divestments in this market;
- Key mergers and acquisitions formed by these companies;
- Business-related strengths and weaknesses of these companies, and insights into the opportunities and threats facing them.
Key features of this report
- Market dynamics of the Eastern European pharmaceutical market during the period 2004-08.
- Key market drivers and resistors.
- Trends of the Eastern European pharmaceutical market.
- Identification of the top 10 players in the Eastern European pharmaceutical market .
- Company analysis and market share of the top 10 players in the Eastern European pharmaceutical market.
Scope of this report
- Learn from the strategies of the Eastern European pharmaceutical companies to target future growth markets effectively, avoid their mistakes, replicate their successes and learn of the threats they face.
- Benchmark your performance against the leading Eastern European pharmaceutical companies using market share data by company and comprehending their strategies.
- Understand the major issues affecting the Eastern European pharmaceutical market.
- Predict the key growth areas in the Eastern European pharmaceuticals market arising from the government’s initiative to promote generics in the region.
Key Market Issues
- Parallel trade: Increasing incidence of parallel traded products will impact companies operating in the region resulting in potential loss of sales eventually affecting cash flows and bringing down innovation in drug development.
- Complex pricing: Complex drug pricing, reimbursement and purchasing policies will affect the development of new drugs thus affecting the growth of Eastern European pharmaceutical market.
- Insufficient funds: Inadequate funding from the government may slowdown the development of the pharmaceutical industry in Eastern Europe.
- Regulatory hurdles: Increasing due diligence and compliance with standards leads to cost overrun and delay in new product launches.
Key findings from this report
- The Eastern European market is valued at $25,417m as of 2008, which is an increase of 19.9% over 2007. The industry witnessed a CAGR of 19.6% during 2004–08.
- Poland, Russia and Hungary lead the Eastern European pharmaceutical market and together contributed 62.1% of total market value in 2008.
- Novartis lead the Eastern European pharmaceutical market with a market share of 7.1% in 2008, followed by Sanofi-Aventis (6.1%) and GSK (4.9%).
- Parallel trade in Eastern Europe plays an important role influencing the multi-nationals’ branded products, which results in potential loss of sales and brings down the activity of innovative drug development.
Key questions answered
- What was the market size of the Eastern European pharmaceutical market in 2008?
- What are the trends in the Eastern European pharmaceutical market?
- Who are the top 10 players in the market?
- What is the market share of each of the companies?
- What are the growth strategies of the top 10 companies?
About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
(Due to the length of these URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser’s URL address field. Remove the space if one exists.)
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
